vs
Side-by-side financial comparison of BioNTech SE (BNTX) and Grab Holdings Ltd (GRAB). Click either name above to swap in a different company.
BioNTech SE is the larger business by last-quarter revenue ($1.5B vs $1.5B, roughly 1.0× Grab Holdings Ltd). Grab Holdings Ltd runs the higher net margin — 1.8% vs -1.9%, a 3.6% gap on every dollar of revenue.
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
Grab Holdings Inc. is a Singaporean multinational technology company headquartered in one-north, Singapore. It is the developer of a super-app for ride-hailing, food delivery, and digital payment services on mobile devices. It operates in Singapore, Malaysia, Cambodia, Indonesia, Myanmar, the Philippines, Thailand, and Vietnam.
BNTX vs GRAB — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2024
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $1.5B |
| Net Profit | $-28.7M | $26.0M |
| Gross Margin | — | 43.1% |
| Operating Margin | -3.1% | -2.5% |
| Net Margin | -1.9% | 1.8% |
| Revenue YoY | — | — |
| Net Profit YoY | — | — |
| EPS (diluted) | — | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $1.5B | — | ||
| Q2 25 | $260.8M | — | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | $1.2B | — |
| Q3 25 | $-28.7M | — | ||
| Q2 25 | $-386.6M | — | ||
| Q4 24 | — | $26.0M | ||
| Q3 24 | $198.1M | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | 43.1% | ||
| Q3 24 | — | — |
| Q3 25 | -3.1% | — | ||
| Q2 25 | -192.1% | — | ||
| Q4 24 | — | -2.5% | ||
| Q3 24 | 0.8% | — |
| Q3 25 | -1.9% | — | ||
| Q2 25 | -148.2% | — | ||
| Q4 24 | — | 1.8% | ||
| Q3 24 | 15.9% | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | $0.01 | ||
| Q3 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $3.0B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $6.4B |
| Total Assets | — | $9.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | $3.0B | ||
| Q3 24 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | $6.4B | ||
| Q3 24 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | $9.3B | ||
| Q3 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $591.0M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 22.73× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | $591.0M | ||
| Q3 24 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | 22.73× | ||
| Q3 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
